Specifically, we aimed to relate rsFC changes to aging, Aβ and tau pathology, APOE4 genotype, and longitudinal memory performance in the PREVENT-AD cohort [44] of cognitively unimpaired older adults with this preregistered study [45]. This evidence concerns the gene MAPT and Alzheimer disease.